This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sato, N. Articles by Frackelton, A. R. Search for Related Content PubMed PubMed Citation Articles by Sato, N. Articles by Frackelton, A. R., Jr

American Journal of Pathology, Vol 142, 1119-1130, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Platelet-derived growth factor indirectly stimulates angiogenesis in vitro

N Sato, JG Beitz, J Kato, M Yamamoto, JW Clark, P Calabresi, A Raymond and AR Frackelton Jr
Department of Medicine, Roger Williams Cancer Center, Providence, Rhode Island.

We evaluated the effect of platelet-derived growth factor (PDGF) on capillary formation using an in vitro angiogenesis model system in which microvascular fragments and myofibroblasts (Mfs) isolated from rat epididymal lipid tissues were grown in co-culture. In this system Mfs induce capillary formation by producing an endothelial cell growth factor and by secreting extracellular matrix components that cause endothelial cells to form cordlike structures. Addition of PDGF enhances in vitro capillary growth. Although some recently described microvascular endothelial cells display PDGF receptors and respond to PDGF, we found no evidence for direct PDGF action on the rat epididymal microvascular endothelial cells. Rather, we found that PDGF increased the proliferation of Mfs, as well as the production of Mf-derived endothelial cell growth factor and matrix collagen type I. Our results suggest that even in cases where the microvasculature lacks PDGF receptors, PDGF may accelerate capillary formation by activating connective tissue cells in the vicinity of endothelial cells.

This article has been cited by other articles:

				J. O. Hollinger, C. E. Hart, S. N. Hirsch, S. Lynch, and G. E. Friedlaender Recombinant Human Platelet-Derived Growth Factor: Biology and Clinical Applications J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 48 - 54. [Abstract] [Full Text] [PDF]

				M.W. Laschke, A. Elitzsch, B. Vollmar, P. Vajkoczy, and M.D. Menger Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions Hum. Reprod., January 1, 2006; 21(1): 262 - 268. [Abstract] [Full Text] [PDF]

				S. S. W. Ng, G. R. MacPherson, M. Gutschow, K. Eger, and W. D. Figg Antitumor Effects of Thalidomide Analogs in Human Prostate Cancer Xenografts Implanted in Immunodeficient Mice Clin. Cancer Res., June 15, 2004; 10(12): 4192 - 4197. [Abstract] [Full Text] [PDF]

				R. CAO, E. BRAKENHIELM, X. LI, K. PIETRAS, J. WIDENFALK, A. OSTMAN, U. ERIKSSON, and Y. CAO Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-{alpha}{alpha} and -{alpha}{beta} receptors FASEB J, October 1, 2002; 16(12): 1575 - 1583. [Abstract] [Full Text] [PDF]

				L. J. Metheny-Barlow, B. Flynn, H. E. van Gijssel, A. Marrogi, and B. I. Gerwin Paradoxical Effects of Platelet-Derived Growth Factor-A Overexpression in Malignant Mesothelioma . Antiproliferative Effects In Vitro and Tumorigenic Stimulation In Vivo Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 694 - 702. [Abstract] [Full Text] [PDF]

				A. D. Laird, P. Vajkoczy, L. K. Shawver, A. Thurnher, C. Liang, M. Mohammadi, J. Schlessinger, A. Ullrich, S. R. Hubbard, R. A. Blake, et al. SU6668 Is a Potent Antiangiogenic and Antitumor Agent That Induces Regression of Established Tumors Cancer Res., August 1, 2000; 60(15): 4152 - 4160. [Abstract] [Full Text]

				A. Francki, A. D. Bradshaw, J. A. Bassuk, C. C. Howe, W. G. Couser, and E. H. Sage SPARC Regulates the Expression of Collagen Type I and Transforming Growth Factor-beta 1 in Mesangial Cells J. Biol. Chem., November 5, 1999; 274(45): 32145 - 32152. [Abstract] [Full Text] [PDF]

				C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF]

				T. A. T. Fong, L. K. Shawver, L. Sun, C. Tang, H. App, T. J. Powell, Y. H. Kim, R. Schreck, X. Wang, W. Risau, et al. SU5416 Is a Potent and Selective Inhibitor of the Vascular Endothelial Growth Factor Receptor (Flk-1/KDR) That Inhibits Tyrosine Kinase Catalysis, Tumor Vascularization, and Growth of Multiple Tumor Types Cancer Res., January 1, 1999; 59(1): 99 - 106. [Abstract] [Full Text] [PDF]

				A. Stratmann, W. Risau, and K. H. Plate Cell Type-Specific Expression of Angiopoietin-1 and Angiopoietin-2 Suggests a Role in Glioblastoma Angiogenesis Am. J. Pathol., November 1, 1998; 153(5): 1459 - 1466. [Abstract] [Full Text] [PDF]

				J. Krupinski, R. Issa, T. Bujny, M. Slevin, P. Kumar, S. Kumar, and J. Kaluza A Putative Role for Platelet-Derived Growth Factor in Angiogenesis and Neuroprotection After Ischemic Stroke in Humans Stroke, March 1, 1997; 28(3): 564 - 573. [Abstract] [Full Text]

				T. Yoshimoto, K. Houkin, A. Takahashi, and H. Abe Angiogenic Factors in Moyamoya Disease Stroke, December 1, 1996; 27(12): 2160 - 2165. [Abstract] [Full Text]